• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number G35341
Medical Device Problem Codes Biocompatibility (2886); Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Unspecified Infection (1930); Inflammation (1932)
Date of Event 09/10/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturer ref# pr (b)(4).Blank fields on this form indicate the information is unknown or unavailable.Investigation is still in progress.
 
Event or Problem Description
Description of event according to initial reporter: successful case and outcome.Patient returned a week later with infected aorta.He was questioned to have infection before the case, but unconfirmed.Patient outcome: the patient is scheduled for an endograft explant of the device on the (b)(6) 2021.The patient had an enlarged aneurism, high white count.
 
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Additional Manufacturer Narrative
Manufacturer ref# (b)(4).Summary of investigational findings: this complaint is related to (b)(4) (manufacturer ref#3002808486-2021-01937) 69-year-old male patient received a tevar (thoracic endovascular aortic repair) for a descending thoracic aortic aneurysm.Two devices were used, zta-p-30-109-w (e4125427, complaint device)) and zta-p-30-109-w (e4016600, complaint device).The operation was successful with no difficulties experienced but a week later the patient returned with infected aorta.It was questioned if the patient had an infection before the operation but it was unconfirmed.Patient was scheduled for an explant surgery on (b)(6) 2021, and it is noticed that the issue has been resolved.Imaging review has been performed by cri on 15oct2021 and was based on one preoperative ct.Relevant findings and impressions: there is aneurysmal dilation of the mid descending ta to maximum diameter of 41 x 38 mm.There is a focal area of mild stranding or adventitial thickening at the distal sac on the left posterolateral aspect.No other remarkable abnormalities are seen around the aorta.In retrospect, this stranding could be a sign of an indolent aortic infection prior to implantation but is non-specific and very subtle.The scan is otherwise unremarkable for signs of a pre-existing infection.The cause of the reported aortic infection cannot be determined from the imaging and information provided.Most likely causes are an indolent underlying infection at the time of repair resulting in bacteremia, contamination of devices/instruments at the time of implantation, or a postoperative infection resulting in bacteremia.Review of device history record gave no indication of the device being produced outside of specifications.Per ifu infection in the endovascular graft is a known potential adverse event.Conclusively, possible explanations could be pre-existing infection, contamination of device/instrument, or postoperative infection but it is not possible to determine the exact cause to the infected stent graft.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH ALPHA¿ THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS
Common Device Name
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
Manufacturer (Section G)
WILLIAM COOK EUROPE
sandet 6, dk-4632
bjaeverskov
Manufacturer Contact
lissi walmann
sandet 6, dk-4632
bjaeverskov 
56868686
MDR Report Key12538756
Report Number3002808486-2021-01835
Device Sequence Number4079686
Product Code MIH
UDI-Device Identifier10827002353418
UDI-Public(01)10827002353418(17)240621(10)E4125427
Combination Product (Y/N)N
Initial Reporter StateUT
Initial Reporter CountryUS
PMA/510(K) Number
P140016
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/21/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Expiration Date06/21/2024
Device Model NumberG35341
Device Catalogue NumberZTA-P-30-109-W
Device Lot NumberE4125427
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/10/2021
Supplement Date Received by Manufacturer02/18/2022
Initial Report FDA Received Date09/28/2021
Supplement Report FDA Received Date02/21/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/21/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age69 YR
Patient SexMale
-
-